[Determination of noradrenaline, of dopamine and dihydroxyphenylacetic acid in certain nuclei of rat brain].
D000818:Animals; D001205:Ascorbic Acid / Q000032:analysis; D002395:Catecholamines / Q000378:metabolism; D002421:Caudate Nucleus / Q000032:analysis*; D002855:Chromatography, Thin Layer; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000032:analysis*; D005260:Female; D005470:Fluorometry; D006220:Haloperidol / Q000494:pharmacology; D007031:Hypothalamus / Q000032:analysis*; D008297:Male; D009638:Norepinephrine / Q000032:analysis*; D010648:Phenylacetates / Q000032:analysis*; D011339:Probenecid / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D014191:Tranylcypromine / Q000494:pharmacology
D002395:Catecholamines; D010648:Phenylacetates; D014191:Tranylcypromine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D006220:Haloperidol; D011339:Probenecid; D001205:Ascorbic Acid; D004298:Dopamine; D009638:Norepinephrine
Dosage de la noradrénaline, de la dopamine et de l'acide dihydroxyphénylacétique dans certains noyaux du cerveau de rat.